High materiality7/10
Protagonist Therapeutics price target raised to $180 from $153 at Barclays
Why it may matterVerify against the original reporting
Buy
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Barclays raises PTGX target to $180 from $153; price $147.75.
- Barclays raises PTGX target to $180; price $147.75.
Key facts
- 01
Target: $180
- 02
Posted price: $147.75
- 03
Analyst firm: Barclays
- 04
Analyst: Etzer Darout
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.